72 related articles for article (PubMed ID: 16213721)
41. Synthesis and monoamine transporter affinity of 3-aryl substituted trop-2-enes.
Krunic A; Mariappan SV; Reith ME; Dunn WJ
Bioorg Med Chem Lett; 2005 Dec; 15(24):5488-93. PubMed ID: 16202585
[TBL] [Abstract][Full Text] [Related]
42. Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.
Indarte M; Madura JD; Surratt CK
Proteins; 2008 Feb; 70(3):1033-46. PubMed ID: 17847094
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
[TBL] [Abstract][Full Text] [Related]
44. Azidobupramine, an Antidepressant-Derived Bifunctional Neurotransmitter Transporter Ligand Allowing Covalent Labeling and Attachment of Fluorophores.
Kirmeier T; Gopalakrishnan R; Gormanns V; Werner AM; Cuboni S; Rudolf GC; Höfner G; Wanner KT; Sieber SA; Schmidt U; Holsboer F; Rein T; Hausch F
PLoS One; 2016; 11(2):e0148608. PubMed ID: 26863431
[TBL] [Abstract][Full Text] [Related]
45. Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.
Motel WC; Healy JR; Viard E; Pouw B; Martin K; Matsumoto RR; Coop A
Bioorg Med Chem Lett; 2013 Dec; 23(24):6920-6922. PubMed ID: 24211020
[TBL] [Abstract][Full Text] [Related]
46. Neurotransmitter and psychostimulant recognition by the dopamine transporter.
Wang KH; Penmatsa A; Gouaux E
Nature; 2015 May; 521(7552):322-7. PubMed ID: 25970245
[TBL] [Abstract][Full Text] [Related]
47. Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling.
Lapinsky DJ; Velagaleti R; Yarravarapu N; Liu Y; Huang Y; Surratt CK; Lever JR; Foster JD; Acharya R; Vaughan RA; Deutsch HM
Bioorg Med Chem; 2011 Jan; 19(1):504-12. PubMed ID: 21129986
[TBL] [Abstract][Full Text] [Related]
48. X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine.
Penmatsa A; Wang KH; Gouaux E
Nat Struct Mol Biol; 2015 Jun; 22(6):506-508. PubMed ID: 25961798
[TBL] [Abstract][Full Text] [Related]
49. A novel photoaffinity ligand for the dopamine transporter based on pyrovalerone.
Lapinsky DJ; Aggarwal S; Huang Y; Surratt CK; Lever JR; Foster JD; Vaughan RA
Bioorg Med Chem; 2009 Jun; 17(11):3770-4. PubMed ID: 19442525
[TBL] [Abstract][Full Text] [Related]
50. C(8)-substituted 1-azabicyclo[3.3.1]non-3-enes: a novel scaffold for muscarinic receptor ligands.
Kim MG; Bodor ET; Harden TK; Kohn H
Bioorg Med Chem; 2004 May; 12(9):2357-67. PubMed ID: 15080933
[TBL] [Abstract][Full Text] [Related]
51. QSAR and molecular modelling of antimuscarinic 7-amino-1-hydroxy-5-heptyn-2-ones.
Mager PP; Mager H; Walther H
Drug Des Discov; 1993 Jun; 10(2):135-56. PubMed ID: 8399998
[TBL] [Abstract][Full Text] [Related]
52. Thermal Stability of Dopamine Transporters.
Kukk S; Stepanov V; Järv J
J Membr Biol; 2015 Aug; 248(4):775-81. PubMed ID: 25812533
[TBL] [Abstract][Full Text] [Related]
53. A short update on the structure of drug binding sites on neurotransmitter transporters.
Gabrielsen M; Sylte I; Dahl SG; Ravna AW
BMC Res Notes; 2011 Dec; 4():559. PubMed ID: 22192271
[TBL] [Abstract][Full Text] [Related]
54. MUSCARINIC RECEPTOR PROBES BASED ON AMINE CONGENERS OF PIRENZEPINE AND TELENZEPINE.
Jacobsont KA; Kartont Y; Baumgold J
Bioorg Med Chem Lett; 1992 Aug; 2(8):845-850. PubMed ID: 38213641
[TBL] [Abstract][Full Text] [Related]
55. [On the amination of benzhydrol].
CANTAREL R
C R Hebd Seances Acad Sci; 1947 Oct; 225(15):638-40. PubMed ID: 18921268
[No Abstract] [Full Text] [Related]
56. New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders.
Newman AH; Ku T; Jordan CJ; Bonifazi A; Xi ZX
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():609-628. PubMed ID: 33411583
[TBL] [Abstract][Full Text] [Related]
57. Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders.
Zou MF; Cao J; Abramyan AM; Kopajtic T; Zanettini C; Guthrie DA; Rais R; Slusher BS; Shi L; Loland CJ; Newman AH
J Med Chem; 2017 Dec; 60(24):10172-10187. PubMed ID: 29227643
[TBL] [Abstract][Full Text] [Related]
58. N-8-Substituted benztropinamine analogs as selective dopamine transporter ligands.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2005 Dec; 15(24):5419-23. PubMed ID: 16213721
[TBL] [Abstract][Full Text] [Related]
59. The effect of 6-substituted-4',4"-difluorobenztropines on monoamine transporters and the muscarinic M1 receptor.
Grundt P; Kopajtic TA; Katz JL; Newman AH
Bioorg Med Chem Lett; 2004 Jun; 14(12):3295-8. PubMed ID: 15149693
[TBL] [Abstract][Full Text] [Related]
60. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
